Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development-Reference-Cited by-同舟云学术

Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development

Published:2019-08-09 Issue:2 Volume:71 Page:670-685
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Schumacher Justin D.¹^ORCID,Kong Bo¹^ORCID,Wu Jason¹,Rizzolo Daniel¹,Armstrong Laura E.¹,Chow Monica D.²,Goedken Michael³,Lee Yi‐Horng²,Guo Grace L.¹⁴⁵

Affiliation:

1. Department of Pharmacology and Toxicology Rutgers University Piscataway NJ

2. Department of Surgery Robert Wood Johnson University Hospital New Brunswick NJ

3. Research Pathology Services Rutgers University Piscataway NJ

4. Environmental and Occupational Health Sciences Institute Rutgers University Piscataway NJ

5. VA New Jersey Health Care System East Orange NJ

Funder

National Institute of General Medical Sciences

Bristol-Myers Squibb

U.S. Department of Veterans Affairs

National Institute of Environmental Health Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30810

Reference36 articles.

1. Hepatic stellate cells as key target in liver fibrosis

2. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain

3. FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4

4. The Fibroblast Growth Factor signaling pathway

5. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-Pyrazol amide derivatives: A multi-scale in silico modelling approach;Computers in Biology and Medicine;2024-09

2. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications;Medical Review;2024-07-01

3. Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies;Biomedicines;2024-06-24

4. Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy;Hepatology Communications;2024-05-22

5. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases;The Journal of Infection in Developing Countries;2024-04-30